News Articles and Montana BioScience Alliance Newsletters
Fifty-eight high school graduates from across Montana have been selected for their effort and potential as the seventh class of Montana State University’s Hilleman Scholars Program, which is named after Maurice Hilleman, one of the state’s most influential, but least known, native sons.
Manually converting FASTQs to VCFs, importing these into VarSeq, and building projects from scratch is adequate when you have only a handful of cases per week. But as you start ramping up production, the key to your lab’s success quickly becomes how quickly and efficiently you can get to the reporting of your analysis. This blog will explain how you can automate the VCF and VarSeq Project generation process that requires only a few commands. This will expedite your path to analysis […]
Tonix Pharmaceuticals has received a grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to support development of TNX-1300 a recombinant enzyme that efficiently degrades and metabolizes cocaine. In 2021, more than 24,900 individuals in the U.S. died from drug overdose deaths involving cocaine.
Endosymbionts are little critters that actually live inside the cells of other organisms. A University of Montana researcher recently earned a $1.5 million grant from the National Science Foundation to study these organisms – especially how they interact with their hosts and the environment – which could help improve health for a huge swath of the world’s population.
When future astronauts heading to Mars sit down to a hearty supper in their spaceship, they may dine on a nutritious, meat-like product made from a microbe that Montana State University scientists discovered in a Yellowstone National Park hot spring.
When her husband was undergoing cancer treatment, Cindy Perez of Southwest Ranches, Fla., learned about a new blood test that could help find early cancers. The 50-year-old said she felt fine, but her husband urged her to take the test anyway.
Studies of interactions between two lab-generated monoclonal antibodies (mAbs) and an essential Epstein-Barr virus (EBV) protein have uncovered targets that could be exploited in designing treatments and vaccines for this extremely common virus.
As a new year begins in Congress, the Biotechnology Innovation Organization (BIO) is carrying over many of its legislative priorities from last year.
Administrative Supplements to Promote Diversity in Research and Development Small Businesses – SBIR/STTR
Contract Pre-solicitation for R&D that will contribute toward ARPA-H mission needs and SBIR program objectives.
View the Spring 2024 Newsletter Newsletter now!
View the Winter II 2024 Newsletter now!